Tapinarof, also known as benvitimod and sold under the brand name Vtama, is a medication used for the treatment of plaque psoriasis. The medication is applied to the skin. Besides its use in medicine, tapinarof is a naturally occurring compound found in bacterial symbionts of nematodes which has antibiotic properties.
The medication acts as an aryl hydrocarbon receptor agonist.
Tapinarof was approved for medical use in the United States in May 2022. The US Food and Drug Administration (FDA) considers it to be a first-in-class medication.